Ado-trastuzumab emtansine Intravenous and Disopyramide Sustained-Release Capsules
Determining the interaction of Ado-trastuzumab emtansine Intravenous and Disopyramide Sustained-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-trastuzumab emtansine, Ado-Trastuzumab Emtansine
Generic Name: disopyramide
Brand name: Norpace, Norpace CR
Synonyms: Disopyramide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine Intravenous-DisperMox
- Ado-trastuzumab emtansine Intravenous-Disposable Enema rectal
- Ado-trastuzumab emtansine Intravenous-Disulfiram
- Ado-trastuzumab emtansine Intravenous-Dithol Solution
- Ado-trastuzumab emtansine Intravenous-Ditropan
- Ado-trastuzumab emtansine Intravenous-Ditropan XL
- Disopyramide Sustained-Release Capsules-Adox Pak 2/100
- Disopyramide Sustained-Release Capsules-Adoxa
- Disopyramide Sustained-Release Capsules-Adoxa CK
- Disopyramide Sustained-Release Capsules-Adoxa Pak
- Disopyramide Sustained-Release Capsules-Adoxa Pak 1/100
- Disopyramide Sustained-Release Capsules-Adoxa Pak 1/150